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Wheat has only recently been added to the 
human diet (since the Neolithic age, i.e., roughly 
12,000 years ago; Charmet, 2011). Today wheat 
has become the world’s major staple, and wheat 
products are widely used ingredients in pro-
cessed foods. Wheat consumption correlates with 
certain disorders like wheat allergies and espe-
cially celiac disease (Shewry et al., 2003). Celiac 
disease is a common small intestinal enteropa-
thy caused by dietary gluten in wheat, barley, 
and rye and affects 1% of most populations 
(Fasano et al., 2003; Green and Cellier, 2007; 
Di Sabatino and Corazza, 2009; Schuppan et al., 
2009) Wheat gluten represents a family of largely 
water-insoluble storage proteins, subdivided 
into gliadins and glutenins, whereas other pro-
teins are extractable as water-soluble albumins 
and salt-soluble globulins (Shewry et al., 2003; 
Wieser, 2007). Because of their unusual struc-
ture, with a high proline and glutamine con-
tent, the gluten proteins are partly resistant to 
intestinal enzymes, which leads to several non-
degraded immunogenic peptides that can be 
sensed by the intestinal immune system. These 
gluten peptides are bound by the human 
lymphocyte antigen HLA-DQ2 or HLA-DQ8 
(the major and necessary genetic predisposi-
tion for celiac disease) on intestinal antigen-
presenting cells, and this binding is potentiated 
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Ingestion of wheat, barley, or rye triggers small intestinal inflammation in patients with 
celiac disease. Specifically, the storage proteins of these cereals (gluten) elicit an adaptive 
Th1-mediated immune response in individuals carrying HLA-DQ2 or HLA-DQ8 as major 
genetic predisposition. This well-defined role of adaptive immunity contrasts with an ill-
defined component of innate immunity in celiac disease. We identify the -amylase/trypsin 
inhibitors (ATIs) CM3 and 0.19, pest resistance molecules in wheat, as strong activators of 
innate immune responses in monocytes, macrophages, and dendritic cells. ATIs engage the 
TLR4–MD2–CD14 complex and lead to up-regulation of maturation markers and elicit 
release of proinflammatory cytokines in cells from celiac and nonceliac patients and in 
celiac patients’ biopsies. Mice deficient in TLR4 or TLR4 signaling are protected from 
intestinal and systemic immune responses upon oral challenge with ATIs. These findings 
define cereal ATIs as novel contributors to celiac disease. Moreover, ATIs may fuel  
inflammation and immune reactions in other intestinal and nonintestinal immune disorders.
© 2012 Junker et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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RESULTS
Gliadin digests induce innate immune responses
Human monocytic THP-1 and U937 cells were exposed to 
pepsin/trypsin (PT)-digested gliadin mimicking intestinal di-
gestion. PT-digested zein, a mixture of storage proteins from 
corn which is functional homologous to gliadin but lacks 
immunogenic peptides, served as a negative control. PT glia-
din but not zein caused a dose-dependent secretion of IL-8, 
TNF, and MCP-1 (monocyte chemotactic protein-1) in 
both cell lines (Fig. 1, A and B; and not depicted) in ac-
cordance with other studies (Nikulina et al., 2004; Cinova 
et al., 2007). To rule out LPS contamination as a trigger of 
innate responses, gliadin, LPS, and TNF were digested 
with proteinase K to eliminate peptide-induced responses. 
Both TNF and PT gliadin lost their stimulatory capacity, 
whereas LPS was still able to induce IL-8 (Fig. 1 C), indi-
cating that the stimulatory effect of gliadin was caused by 
protein and not LPS contamination. Interestingly, exposure 
of primary human monocyte-derived DCs to PT gliadin 
and LPS led to a similar cytokine profile in response to 
gliadin. In contrast, the intestinal epithelial cell line HT29 
showed only a minor response (not depicted).
Moreover, DCs from celiac patients, both on gluten-free 
and on regular diet, and DCs from healthy controls strongly 
secreted IL-8 upon gliadin stimulation, with no significant 
differences between these groups, which is in line with prior 
data (Fig. 1 D; Rakhimova et al., 2009). In addition, DCs up-
regulated the cell surface maturation markers CD25, CD80, 
CD83, and CD86 upon exposure to PT gliadin and LPS but 
not to zein (Fig. 1 E). -Gliadin peptide p31-43, which was 
shown by others to increase IL-15 secretion in celiac biopsies 
(Maiuri et al., 2003), did not elicit secretion of IL-8, TNF, or 
MCP-1 in monocytic or intestinal epithelial cell lines even at 
high concentrations (Fig. 1 F and not depicted).
Innate immune responses to gliadin are mediated via TLR4
A recent study suggested that gliadin signals via MyD88, a 
key adapter molecule in the TLR–IL-1 pathway (Thomas 
et al., 2006). We studied peritoneal macrophages of C3H/
HeJ mice that lack TLR4 responses because of a spontaneous 
point mutation in the Tlr4 gene. In these mice, keratinocyte-
derived cytokine (KC; IL-8) and TNF secretion was reduced 
to baseline levels after stimulation with PT gliadin and LPS 
compared with syngenic C3H/HeOuJ TLR4-competent 
mice. In macrophages from both mouse strains, the specific 
TLR2 agonist Pam3CSK4 induced indistinguishable KC and 
TNF secretion, confirming otherwise intact MyD88 and TLR 
signaling, and cell viability (Fig. 2, A and B). In addition, 
HEK-293 cells transfected with the human TLR4–CD14–MD2 
complex but not untransfected TLR4-deficient HEK-293 
cells secreted IL-8 in response to gliadin and LPS but not to 
the TLR2 agonist Pam3CSK4 (Fig. 2, C and D). Finally, incu-
bation with anti-TLR4 and CD14 blocking antibodies be-
fore addition of gliadin significantly reduced IL-8 production 
by human DCs, whereas blocking had no effect on TLR2 and 
TLR3 stimulation (Fig. 2 E).
by the ubiquitous enzyme tissue transglutaminase (TG2), 
the celiac disease autoantigen (Dieterich et al., 1997). TG2 
deamidates certain glutamine residues in (immunodomi-
nant) gluten peptides to glutamic acid, thereby increasing 
the peptides’ binding affinity to HLA-DQ2 and HLA-DQ8 
and the subsequent T cell activation (Dieterich et al., 1997; 
van de Wal et al., 1998). This results in villus atrophy and 
crypt hyperplasia of the intestinal mucosa, the histological 
hallmarks of celiac disease, and frequent nutrient malab-
sorption and may promote certain celiac disease–associated 
autoimmune disorders (Green and Cellier, 2007; Di Sabatino 
and Corazza, 2009; Schuppan et al., 2009).
Although several HLA-DQ2– and HLA-DQ8–restricted 
gluten peptides that trigger the adaptive immune response in 
celiac disease have been identified (Molberg et al., 1998; 
Anderson et al., 2000; Shan et al., 2002), only 2–5% of indi-
viduals expressing these HLAs develop the disease, indicating 
additional mechanisms of celiac disease pathogenesis, espe-
cially innate immune activation. The innate immune system 
provides an early response to many microbial and chemical 
stimuli and is critical for successful priming of adaptive im-
munity. Responsive innate cells are primarily macrophages, 
monocytes, DCs, and polymorphonuclear leukocytes that by 
means of their pattern-recognition receptors, such as TLRs, 
induce the release of proinflammatory cytokines and chemo-
kines, resulting in recruitment and activation of additional 
inflammatory cells (Medzhitov, 2007).
Thus, peptides p31-43 or p31-49 from -gliadin that lack 
adaptive stimulatory capacity were incriminated as triggers of 
innate immunity as they induced IL-15 and Cox-2 expression 
in patients’ biopsies (Maiuri et al., 2003) and MHC class I 
polypeptide–related sequence A (MICA) on intestinal epithelial 
cells (Hüe et al., 2004). However, these studies were difficult 
to reproduce in cell culture, and no receptor responsible for 
the observed effects could be identified.
In cell culture, gliadin was reported to induce increased 
expression of co-stimulatory molecules and the produc-
tion of proinflammatory cytokines in monocytes and DCs 
(Nikulina et al., 2004; Cinova et al., 2007). In addition, 
the chemokine receptor CXCR3 was implicated in in-
creased intestinal epithelial permeability upon gliadin chal-
lenge in a MyD88-dependent manner (Thomas et al., 2006; 
Lammers et al., 2008). However, no defined gliadin pep-
tide was reproducibly identified. Collectively, a clear picture 
of the role of the innate immune system in celiac disease has 
not emerged.
In this study, we show that members of the nongluten 
-amylase/trypsin inhibitor (ATI) family contained in wheat 
and related cereals are strong inducers of innate immune re-
sponses in human and murine macrophages, monocytes, and 
DCs. ATI family members activate the TLR4–MD2–CD14 
complex and elicit strong innate immune effects not only 
in vitro but also in vivo after oral or systemic challenge. Our 
findings have broad implications not only for celiac disease 
but also for other intestinal inflammatory disorders of the 
gastrointestinal tract.
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increased in supernatants of gliadin-stimulated macrophages 
from C57BL/6J wild-type mice, suggesting that both the 
MyD88-dependent and -independent pathways (Fitzgerald 
et al., 2003) are activated by gliadin (Fig. 2 G).
Characterization of the TLR4 stimulatory  
activity in gliadin extracts
Gliadins from the pure wheat strain “Rektor” were separated 
into their , , and  fractions via HPLC, and their PT digests 
were tested on THP-1 monocytic cells. Neither the - nor the 
TLR4 is unique in its ability to mediate cellular activa-
tion via the adapter molecule MyD88 and IRF3 (interferon 
regulatory factor 3). Compared with C57BL/6J wild-type 
mice, peritoneal macrophages from MyD88 knockout mice 
displayed markedly reduced KC and TNF secretion after 
gliadin and LPS stimulation, indicating signaling via MyD88. 
The TLR3 agonist poly I:C served as a positive control be-
cause TLR3 does not use MyD88 as an adapter protein for 
signaling (Fig. 2 F and not depicted). RANTES, which is 
secreted upon activation of the alternative pathway, was also 
Figure 1. Gliadin leads to secretion of in-
flammatory cytokines. (A and B) THP-1 cells 
were treated with PT gliadin, and IL-8 (A) and 
MCP-1 (B) secretion was measured. LPS and  
PT zein served as positive and negative controls, 
respectively. (C) Proteinase K digests of PT glia-
din, TNF, and LPS were added to THP-1 cells, and 
IL-8 secretion was used as read out of innate 
activation. (D) PT gliadin stimulation of mono-
cyte-derived DCs of healthy controls (n = 10) and 
of patients with celiac disease on a gluten-free 
(gfd; n = 8) or regular diet (n = 3). Graph shows 
one representative patient per group. (E) DCs of 
healthy controls were stimulated with PT gliadin 
and subjected to analysis by flow cytometry. 
The dark gray and dotted histograms represent 
PT gliadin and LPS stimulation, respectively, the 
light gray histograms show PT zein stimulation, 
and the dashed lines represent the unstimulated 
control. (F) HT29, U937, and THP-1 cells were 
stimulated with gliadin peptide p31-43 or a 
scrambled control peptide, and IL-8 secretion 
was measured. *, P < 0.05 versus negative con-
trol (if not indicated otherwise); graphs in A–C, E, 
and F illustrate representative data from one of 
at least three independent experiments, all per-
formed in triplicates. Error bars depict standard 
errors of the mean.
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stimulatory capacity (Fig. 3 A). Furthermore, 1.2- and 5-
gliadins strongly induced IL-8 secretion in TLR4-transfected 
but not untransfected HEK-293 cells (Fig. 3, B and C).
Next, we tested synthetic overlapping 20mers covering the 
5-gliadin sequence of 439 aa to identify TLR4-stimulating 
-gliadins, which represent >90% of total gliadin, harbored 
stimulatory activity, whereas IL-8 release was strongly induced 
by PT-digested 1.2- and 5-gliadins (Fig. 3 A). The lack of 
stimulation by - and -gliadins was not caused by toxic effects 
because addition of LPS or whole PT gliadin fully restored the 
Figure 2. Gliadin-induced innate immune  
responses are mediated via TLR4 and via the 
MyD88-dependent and -independent pathway. 
(A and B) KC (murine IL-8; A) and TNF (B) secretion 
in peritoneal macrophages isolated from TLR4-
deficient C3H/HeJ mice compared with C3H/HOuJ 
wild-type mice stimulated with LPS or PT gliadin. 
The TLR2 agonist Pam3CSK4 served as cell viability 
control. (C and D) IL-8 secretion upon PT gliadin 
and LPS stimulation in 293 cells transfected with 
the TLR4–MD2–CD14 complex (C) and in untrans-
fected cells (D). LPS and PMA served as positive 
controls, and the TLR2 agonist Pam3CSK4 served as 
negative control. (E) IL-8 secretion after preincuba-
tion with anti-TLR4 and anti-CD14 antibodies in 
monocyte-derived DC stimulated with PT gliadin 
and LPS. TLR2 agonist Pam3CSK4 and TLR3 agonist 
Poly I:C served as positive controls. (F) TNF secre-
tion in peritoneal macrophages isolated from 
MyD88/ mice compared with C57BL/6J wild-type 
mice upon PT gliadin stimulation. LPS served as 
positive control for the MyD88 knockdown, and 
TLR3 agonist Poly I:C served as cell viability control. 
(G) RANTES secretion in peritoneal macrophages 
isolated from C57BL/6J mice upon LPS, Poly I:C,  
and PT gliadin stimulation. *, P < 0.05 versus  
negative (positive) control (if not indicated other-
wise); all graphs illustrate representative data from 
one of at least three independent experiments,  
and all experiments were performed in triplicates. 
Error bars depict standard errors of the mean.
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Figure 3. Gliadin-induced innate immune responses are elicited by wheat ATI, a protein copurifying with -gliadins. (A) Stimulation of 
THP-1 cells with -, -, 1.2-, and 5-gliadin fractions (all 100 µg/ml) isolated from the pure wheat strain Rektor. Co-incubation of - and -gliadin 
with 100 µg/ml of regular PT gliadin from Sigma-Aldrich served as cell viability control. LPS was used as positive control, whereas PT or PT zein served 
as negative control. (B and C) IL-8 secretion after stimulation with 100 µg/ml -gliadins in TLR4-transfected (B) and in untransfected HEK-293 cells 
(C). 10 ng/ml PMA served as cell viability control. 10 ng/ml LPS, 100 µg/ml PT gliadin, or 100 µg/ml of a PT digest of Rektor gliadin (PT Rektor) served 
as positive control, and 100 µg/ml PT zein, 1 µg/ml Pam3CSK4, or a PT mixture (PT ctrl) served as negative controls. (D) Stimulatory capacity of syn-
thetic overlapping 20mers of 5-gliadin in TLR4-transfected HEK-293 cells. For illustration purposes, 9 fractions each were pooled in the stimulation 
experiments (each fraction at a concentration of 100 µg/ml), while also all 43 fractions were tested individually. LPS served as positive and Pam3CSK4 
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HEK-293 cells, to avoid potential bacterial contaminants (LPS) 
and to ensure correct protein folding (Fig. 4, B and C). Both 
affinity-purified ATIs stimulated TLR4–MD2–CD14-trans-
fected but not untransfected HEK-293 cells, confirming their 
TLR4-stimulating activity. In line with eukaryotic expression, 
the stimulatory activity of recombinant CM3 and 0.19 was 
maintained after additional purification using an endotoxin 
depletion column (Fig. 4 D and not depicted). In addition, 
overexpression of both CM3 and 0.19 in TLR4–MD2–CD14-
expressing HEK-293 cells strongly induced the canonical and 
the alternative TLR4 pathway (Fig. 4 E). Sequence comparison 
revealed that despite significant differences in primary sequence, 
both CM3 and 0.19 showed five stretches of highly conserved 
amino acid residues clustered around cysteines, indicative of a 
similar secondary structure of both ATIs (Fig. 5 A). Other ATI 
variants that occur in wheat or barley showed similar homol-
ogy, suggestive of comparable biological activity (Fig. 5 B).
In addition, we could demonstrate that reduction and 
alkylation of wheat extracts that are enriched in ATIs com-
pletely abolished any stimulatory activity (Fig. 4 F). This dem-
onstrates that the highly disulfide-linked secondary structure 
of ATIs is necessary to activate TLR4 and that indeed the 
unique ATIs (and no other, less disulfide-linked proteins, 
including the linear gliadins, or nonpeptidic components) 
are the main stimulants of wheat-induced TLR4-dependent 
innate immune reactions.
ATI elicits innate immune responses in vivo
When injected intraperitoneally, water-soluble gliadin (con-
taining ATI) but not zein led to an increase in peripheral KC 
and TNF levels comparable with LPS. In contrast, no response 
was observed in MyD88/ mice (Fig. 6 A and not depicted). 
A recent study implicated the adaptive immune system in 
modulating innate immune responses (Kim et al., 2007). We 
therefore injected water-soluble gliadin into T cell– and B cell–
deficient Rag1/ mice. Rag1/ mice showed cytokine levels 
similar to C57BL/6J mice, indicating that the innate immune 
response was not modulated by adaptive immunity (Fig. 6 B).
Next, we analyzed local intestinal effects of orally ingested 
ATI. C57BL/6J mice were first gavaged with water-soluble glia-
din, LPS, or PBS, followed by analysis of transcripts of proinflam-
matory cytokines in the proximal duodenum. Interestingly, only 
water-soluble gliadin caused an up-regulation of duodenal KC, 
MCP-1, and IL-1 (but not TNF) transcripts (Fig. 6 C). LPS 
did not lead to increased cytokine transcription, which can be 
peptide sequences. Surprisingly, none of the synthetic peptides 
triggered IL-8 secretion by TLR4–CD14–MD2-transfected 
HEK-293 cells (Fig. 3 D). This could have been caused by 
posttranslational modifications of the gliadin or a particular 
secondary structure that was not captured by the synthetic 
peptides. However, most gliadins are not modified posttrans-
lationally, and their structure is well reflected even by smaller 
peptides (Wieser and Koehler, 2008), raising the possibility 
that other wheat proteins contained in the -gliadin prepara-
tion might be responsible for the observed effects. Coomassie 
staining revealed a 15-kD protein contained in the - but not 
the nonreactive - and -gliadin fractions. Mass spectrometry 
characterized this protein as wheat ATI, containing mainly its 
family members CM3 and 0.19 (see sequences shown in 
Fig. 5). As part of the albumin fraction, wheat ATIs are highly 
disulfide-linked, water-soluble proteins that copurify specif-
ically with -gliadins (Pastorello et al., 2007). In line with 
this, a water-soluble gliadin extract that contained a promi-
nent 15-kD band (identified to be ATI) showed a higher stim-
ulatory capacity than PT gliadin (Fig. 3 E, not depicted).
Both untreated and PT-digested ATIs purified from wheat 
induced IL-8 secretion by human DCs (Fig. 3 F and not de-
picted). Furthermore, ATIs elicited up-regulation of the CD4 T 
cell–activating cytokine IL-12 in human DCs, thereby provid-
ing evidence that ATIs may contribute to Th1 polarization 
of gluten-specific CD4 T cells (Fig. 3 G). As for PT gliadin, 
proteinase K digestion abrogated its stimulatory capacity, 
ruling out LPS contamination (Fig. 3 H). Importantly, peri-
toneal macrophages from C57BL/6J but not MyD88/ 
mice secreted KC (IL-8) upon stimulation with ATI (Fig. 3 I). 
Moreover, ATI induced up-regulation of IL-8 secretion in 
TLR4–MD2–CD14-transfected HEK-293 cells as compared 
with untransfected cells (not depicted), and incubation of 
human DCs with blocking TLR4 and CD14 antibodies before 
addition of ATI reduced IL-8 secretion (Fig. 3 J). Overall, these 
results confirmed the signaling pathways identified above with 
crude gliadin or -gliadin and demonstrated that these innate 
immune effects were mediated via the nongluten ATI.
To demonstrate that ATI directly interacts with TLR4, 
coimmunoprecipitation was performed. Biotinylated ATI was 
able to specifically pull down a soluble flag-tagged TLR4/
MD2 fusion protein (Brandl et al., 2005), thereby proving 
their direct interaction (Fig. 4 A).
CM3 and 0.19, the main ATI family members detected by 
mass spectrometry, were recombinantly expressed in eukaryotic 
or PT zein as negative controls. (E and F) Dose response of IL-8 release by monocyte-derived DCs stimulated with water-soluble (ws) gliadin (which is 
enriched in ATI; E) or with purified ATI (F). LPS and water-soluble zein served as positive and negative controls, respectively. (G) Secretion of IL-12 in 
monocyte-derived DCs from healthy subjects upon stimulation with ATI and PT gliadin in the presence of 1,000 U/ml Interferon- as co-stimulatory 
protein. LPS and PT zein served as positive and negative controls, respectively. (H) Effect of proteinase K digestion of ATI and LPS on IL-8 secretion in 
DCs. (I) KC secretion in peritoneal macrophages isolated from MyD88/ mice compared with C57BL/6J wild-type mice upon ATI or water-soluble 
gliadin stimulation. LPS and water-soluble zein served as positive and negative controls, respectively. (J) IL-8 secretion of monocyte-derived DCs  
stimulated with ATI and LPS after preincubation with anti-TLR4 or anti-CD14 antibodies. TLR2 agonist Pam3CSK4 served as positive control. *, P < 0.05 
versus negative (positive) control (if not indicated otherwise); all graphs illustrate representative data from one of at least three independent experiments, 
all performed in triplicates. Error bars depict standard errors of the mean.
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with or without purified ATI. Addition of PT gliadin, the 
33mer, or of ATI alone to biopsies from patients with celiac 
disease in remission induced an increase in IL-8 mRNA ex-
pression. Moreover, the addition of ATI to the (ATI free) 
33mer further elevated IL-8 expression (Fig. 6, F and G).
DISCUSSION
Celiac disease is considered the best-characterized HLA-
linked disease, as its nutritional trigger (gluten), its major 
genetic predisposition, and the adaptive immune responses 
to gluten are well defined. However, additional modulating 
factors, including cereal stimulants of innate immunity, were 
suspected, but their clear identity and signaling receptors 
remained elusive (Maiuri et al., 2003; Nikulina et al., 2004; 
Cinova et al., 2007). In these studies, only MyD88 was iden-
tified as a component of the signaling pathway in gliadin-
 induced innate immunity, whereas TLR4 did not seem to 
play a role as responsible receptor (Nikulina et al., 2004; 
Thomas et al., 2006).
Here, we identified the nongluten ATIs CM3 and 0.19 
and likely other homologous ATI variants as potent activators 
explained by its inactivation at low pH in the stomach and 
by intestinal epithelial alkaline phosphatase activity (Poelstra 
et al., 1997). In addition, KC transcripts were found to be in-
creased only in wild-type but not TLR4-deficient mice. The 
lack of cytokine induction after ingestion of water-soluble 
zein largely excluded an unspecific reaction to uncommon 
nutritional antigens (Fig. 6 D).
Subsequently, C57BL/6 mice were gavaged with purified 
ATI, LPS, or water-soluble zein. As expected ATI increased 
duodenal transcript levels of KC, IL-1, and IL-6 (Fig. 6 E). 
The less pronounced effects with purified ATI as compared 
with water-soluble gliadin are explained by the low ATI con-
centrations used in these experiments (0.075 mg of purified pro-
tein vs. 2 mg of ATI-containing gliadin extract per gram of 
mouse weight).
ATI drives inflammatory responses  
in cultures of celiac intestinal biopsies
Human duodenal biopsies were incubated with PT gliadin 
(containing ATI), purified ATI, or a potent T cell stimula-
tory synthetic 33mer -gliadin peptide (Shan et al., 2002) 
Figure 4. Identification of ATI CM3 and 0.19 as in-
ducers of innate immune responses. (A) Coimmunopre-
cipitation of a soluble flag-tagged TLR4/MD2 fusion protein 
with or without biotinylated ATI. Pull-down was performed 
by streptavidin-agarose. Western blot (WB) analysis using a 
rabbit anti-flag antibody was performed to detect the TLR4/
MD2 fusion protein. The image illustrates representative data 
from one of three independent experiments. (B) CM3 and 
0.19 were expressed in HEK-293 cells and purified as Flag-
tagged molecules, yielding expected molecular masses of  
15 kD and 17 kD, respectively, after 15% SDS-PAGE and 
Western blotting with Flag antibody. There was no expres-
sion in mock (vector only)-transfected cells. 0.19 was not 
secreted into media but could be recovered in SDS/DTT 
buffer (Cell), deoxycholate and Triton X-100 buffer (Sup), 
or the remaining cell pellet. (C) Purity of CM3 and 0.19 
ATI after affinity purification on Flag-agarose (15% SDS-
PAGE) after staining with Coomassie blue or blotting with 
Flag antibody. (B and C) Arrows denote expected molecular 
masses of CM3 and 0.19 ATIs. (D) IL-8 secretion by TLR4–
CD14–MD2-expressing HEK-293 cells after stimulation with 
recombinant ATI. Cells were left untreated or stimulated with 
affinity-purified detergent extracts from mock-transfected 
cells, from recombinant CM3, 0.19, or with ATI isolated from 
wheat (all 5 µg/ml). Controls were 5 µg/ml Flag peptide,  
100 µg/ml PT gliadin, and 10 ng/ml LPS. (E) Effect of expression 
of CM3 and 0.19 in HEK-TLR4 cells on downstream signaling 
of the canonical (pNF-B/p65) and the alternative (pIRF3) 
pathways. Western blots of whole cell lysates (50 µg pro-
tein). (F) Reduction and alkylation (R/A) of enriched ATIs from 
spring wheat (ABic: ammonium bicarbonate extract; AA: 
acetic acid extract). Stimulatory capacity was measured by 
IL-8 secretion in U-937 cells. LPS served as positive control. 
*, P < 0.05 versus negative (positive) control. All graphs  
illustrate representative data from one of at least three  
independent experiments. D and F were performed in  
triplicates. Error bars depict standard errors of the mean.
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in remission a duodenal and rectal gluten challenge increased 
proinflammatory chemokines and cytokines after only 1–4 h 
(Kontakou et al., 1995; Chowers et al., 1997), a time frame 
which is too short to induce adaptive immune responses. Of 
note, the local gluten doses applied in these studies (6–10 g) 
already come close to the doses that we used in mice in vivo. 
Moreover, we can assume that there is increased sensitivity 
toward ATI in patients with celiac disease or gluten sensitiv-
ity compared with healthy controls.
Apart from LPS, other (lower affinity) TLR4 ligands have 
emerged, i.e., heme, fusion proteins of respiratory syncytial 
virus, myeloid-related protein 8, heparan sulfate, tenascin C, 
hyaluronan, and fibronectin (Erridge, 2010). Tenascin C and 
hyaluronan do not require the same coreceptors as LPS, 
and heme does not trigger release of cytokines typical for 
LPS, indicating that the TLR4 complex harbors different 
of TLR4. Based on our data, we believe that this interaction 
of ATI with TLR4 is a major signaling pathway in innate im-
mune reactions to wheat. We did not find activity in gliadins, 
and reduction of disulfide bonds completely abolished TLR4-
stimulating activity in ATI-enriched fractions. However, our 
findings do not completely rule out other, gliadin-dependent 
signaling pathways that still remain to be characterized. The 
highly disulfide-linked ATIs stimulate monocytes, macro-
phages, and DCs in vitro to produce IL-8 and other inflam-
matory cytokines such as IL-12, TNF, MCP-1, or RANTES. 
Notably, feeding ATIs to C57BL/6J mice resulted in up-
regulation of proinflammatory cytokines in their duodenal 
mucosa, which confirms resistance of ATIs to enteric prote-
ases and their stimulatory potential in vivo.
ATI, a “contaminant” in gluten preparations, rather than 
gluten itself might explain observations that in celiac patients 
Figure 5. Sequence alignment of dis-
tinct ATI variants from wheat and barley. 
(A and B) Sequence alignment between CM3 
and 0.19 (A) and between CM3 or 0.19 and 
other ATIs from wheat (CM1, CM2, CM3, 
CM16, CMX1, CMX2, 0.19, and 0.53) and 
barley (CMa, CMb, and CMd; B) using the 
ClustalW program (2.0.12 version). The 
highly conserved cysteine residues are boxed. 
Asterisks, colons, and periods denote iden-
tity, high homology, and low homology of 
amino acid residues, respectively. Similarities 
are much higher among individual ATIs.
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Figure 6. ATI induces innate immune responses in vitro, in vivo, and in duodenal biopsies. (A and B) Intraperitoneal injection of LPS (1 µg/g 
mouse weight), water-soluble (ws) gliadin (500 µg/g mouse weight), or water-soluble zein (500 µg/g mouse weight) into C57BL/6J, MyD88/ (A) and 
Rag1/ (B) mice (n = 4 animals per group). Serum was taken 2 h after injection, and serum cytokine levels were measured by ELISA. (C–E) C57BL/6J  
(C and E), C3H/HeJ (TLR4 deficient; D), and C3H/HOuJ mice (D) were gavaged with LPS (20 µg/g mouse weight), water-soluble gliadin (2 mg/g mouse 
weight), ATI (0.075 mg/g mouse weight), water-soluble zein (2 mg/g mouse weight), or PBS. 4 h after gavage, the mice were euthanized, and duodenal 
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celiac disease (or other inflammatory gastrointestinal diseases) 
have specific defects in negative regulation of TLR4, which 
might affect the subtle balance between intestinal tolerance 
and inflammation.
Importantly, ATIs are the primary resistance molecules of 
cereals to fend off pests and parasites such as the meal bug 
(Ryan, 1990; Cordain, 1999), and more recent breeding of 
high yielding and highly pest-resistant wheat (Ryan, 1990; 
Cordain, 1999; Sands et al., 2009) has led to a drastic increase 
of ATI content (Ryan, 1990). Our finding of ATI as a potent 
stimulator of TLR4 in the intestine might not only be rele-
vant to celiac disease, but is likely to have implications for 
patients with so-called gluten sensitivity and possibly for 
patients with irritable bowel syndrome, inflammatory bowel 
disease, and even nonintestinal inflammation. Patients with 
gluten sensitivity do not have celiac disease, but their symp-
toms improve on a gluten-free (i.e., cereal and therefore ATI 
free) diet, and several case reports documented that other 
intestinal inflammatory conditions improved on a gluten-free 
diet (Verdu et al., 2009; Biesiekierski et al., 2011). Moreover, 
members of the ATI family have been previously character-
ized as allergens in baker’s asthma and gastrointestinal hyper-
sensitivity to wheat (Tatham and Shewry, 2008). It is therefore 
tempting to speculate that their ability to stimulate TLR4 
contributes to their allergenicity, as has been shown recently 
for the main house dust mite allergen Der p2 (Trompette 
et al., 2009). In conclusion, we identify ATIs, nutritional 
proteins from wheat and related cereals, as activators of TLR4 
and inducers of innate immune responses in vitro and in vivo, 
with broad implications not only for the onset and course of 
celiac disease, but also for other intestinal and possibly nonin-
testinal inflammatory diseases.
MATERIALS AND METHODS
Isolation of gliadin fractions and PT digestion of gliadin (PT gliadin). 
Unless otherwise stated, gliadin purchased from Sigma-Aldrich was used for 
experiments. PT-digested gliadin was generated as originally described (Frazer 
et al., 1959), with minor modifications. In brief, gliadin was digested with 
pepsin in 0.1 M HCl, pH 1.8, at 37°C for 4 h, followed by pH adjustment to 
7.8 and digestion with trypsin at 37°C for 4 h (substrate/enzyme ratio of 200:1 
for both reactions). Adjustment of the pH to 4.5 resulted in a precipitate, 
which was removed by centrifugation at 2,500 rpm, and N-tosyl-chloromethyl-
ketone was added to inhibit residual trypsin activity. The supernatant con-
taining the PT gliadin was dialyzed against 10 mM ammonium carbonate, 
pH 7.8 (molecular mass exclusion 1,000 D; Spectra/Por; Serva), sterile filtered, 
and lyophilized. A parallel digest of zein from corn (Sigma-Aldrich) was used 
as negative control.
The water-soluble fraction of gliadin was obtained by incubating 10 g 
gliadin in 50 ml sterile water at 37°C for 8 h under continuous stirring. In-
soluble material was removed by centrifugation, and the supernatant was 
sterile filtered and lyophilized.
ligand-binding sites that can activate variant signaling path-
ways (Erridge, 2010).
LPS-mediated TLR4 receptor signaling involves the 
TLR4–MD2 complex and CD14, a glycosylphosphatidylino-
sitol-anchored cell surface protein that binds LPS, thereby 
amplifying the signal. Downstream signaling can then engage 
two different pathways: either activation of the MyD88 path-
way leading to activation of NF-B and transcriptional up-
regulation of proinflammatory chemokines and cytokines 
such as IL-8, TNF, and MCP-1 or the TIR domain–contain-
ing adapter-inducing interferon- (TRIF)–dependent cas-
cade driving secretion of type I interferons and RANTES 
(Fitzgerald et al., 2003; Kawai and Akira, 2005; McGettrick 
et al., 2006). We demonstrated that TLR4 activation by ATI 
resembles that induced by LPS because it is CD14 dependent 
and engages downstream signaling by MyD88 as well as TRIF. 
However, in contrast to macrophages, in human DCs the 
cytokine profile induced by ATI differed from that induced 
by LPS (only modest secretion of TNF and RANTES; un-
published data).
To induce sufficient adaptive immune responses, antigens 
have to be recognized in the context of an activated innate 
immune system (Iwasaki and Medzhitov, 2004). Bystander 
inflammation, e.g., by viral infections, was implicated as 
innate immune trigger in celiac disease (Schuppan et al., 2009). 
Therefore, the discovery of ATIs as potent nutritional TLR4 
ligands that, in contrast to LPS withstand gastrointestinal deg-
radation, adds an important piece to the puzzle of celiac dis-
ease pathogenesis. Of note, we could not confirm gliadins or 
gliadin peptides, such as p31-43, as innate immune stimula-
tors in our in vitro and in vivo experiments.
As is expected for innate responses, we found a similar 
extent of activation of DCs from healthy controls and celiac 
patients in vitro. This raises the question of how this reaction is 
controlled in the human intestine that generally favors toler-
ance toward food antigens. Several possibilities can be consid-
ered. First, patients with the celiac predisposition may require 
a lower threshold for immune activation and mucosal inflam-
mation. Second, the TLR4 pathway is tightly regulated and 
onset of celiac disease therefore could result either from dys-
regulation of endogenous inhibitory processes or from over-
activation (Liew et al., 2005). Thus, intestinal mucosal TLR4 
expression in active or remitting celiac is increased (Szebeni 
et al., 2007), which could lead to hypersensitivity toward 
stimulation with ATI. Moreover, TLR4 can be negatively 
regulated by intracellular inhibitors, membrane-bound sup-
pressors, receptor degradation, TLR-induced apoptosis, and 
microRNAs (Liew et al., 2005; Sheedy et al., 2010). It will 
therefore be important to determine whether patients with 
samples were snap frozen in liquid nitrogen. Duodenal cytokine mRNA levels were measured by quantitative RT-PCR (n = 4 animals per group).  
(F and G) IL-8 transcript levels after incubation of duodenal biopsies with PT gliadin (PT), -gliadin 33mer, ATI, or 33mer plus ATI (results expressed as 
medians and quartiles). For F, a biopsy obtained from the same patient and incubated with medium alone (M) served as control; for G, an external 
calibrator (cDNA derived from RNA extracted from human duodenum) was used. P-values were derived by Student’s t test: *, P < 0.05 versus negative 
control. Error bars depict standard errors of the mean.
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analysis using a horseradish peroxidase–labeled rabbit anti-flag antibody 
(Sigma-Aldrich).
Reduction and alkylation on enriched ATIs from spring wheat. 
1 mg of a neutral extract enriched in ATIs from spring wheat (extracted with 
50 mM ammonium bicarbonate or 0.05% acetic acid) was reconstituted in 
1 ml of 100 mM Tris, pH 8.5, and incubated with 100 mM dithiothreitol 
(DTT; Promega) at 37°C for 1 h. Samples were alkylated with iodoacet-
amide (Sigma-Aldrich) at a final concentration of 250 mM for 30 min at 
room temperature in the dark. Finally, 200 mM DTT was added to quench 
iodoacetamide, and protein was purified using spin columns (Amicon-Ultra 
3K; EMD Millipore). ATI treated in the same way but without the reducing 
and alkylating agents was used as control. Samples were freeze dried, recon-
stituted in PBS, and filtrated. Then they were added to the monocytic cell 
line U937 (106/ml) in triplicates at a concentration of 50 µg/ml and incu-
bated overnight. IL-8 from cell supernatants was measured by ELISA 
according to the manufacturer’s protocol.
Animals. C3H/HeJ, C3H/HeOuJ, and Rag1/ mice were obtained from 
the Jackson Laboratory. MyD88/ mice were a gift from S. Akira (Osaka 
University, Osaka, Japan; Kawai et al., 1999). Congenic C57BL/6J mice 
served as experimental controls and were bred under the same conditions in 
the same facility. All experiments were performed with mice at age 5–7 wk.
In vivo experiments. Mice were injected intraperitoneally with water-
soluble gliadin, zein (500 µg/g body weight), or LPS (1 µg/g body weight) 
in 200 µl PBS or PBS alone (negative control). 2 h after injection, mice were 
euthanized by ketamine/xylazine administration, and blood was drawn by 
retroorbital bleeding.
Mice were either raised on gluten-free diet (C57BL/6J and MyD88/ 
mice) or put on gluten-free diet for at least 2 wk (C3H/HeJ and C3H/
HeOuJ mice) and starved the night before the experiment. Gluten-free 
standardized diet AIN-76A was obtained from Research Diets. All stimulants 
were diluted in PBS. Mice were administered gliadin, zein (2 mg/g mouse 
weight), LPS (20 µg/g mouse weight), or ATI (0.075 mg/g mouse weight) 
in 200 µl PBS via gavage. Mice were euthanized after 4 h, and the duode-
num was snap frozen in liquid nitrogen.
Cytokine/chemokine assays. The concentration of IL-8, TNF, IL-12, 
MCP-1, RANTES, and mouse IL-8 (KC) in cell culture supernatants and 
serum samples was determined using validated ELISAs (IL-8 and hTNF 
[BD]; MCP-1, hRANTES, mRANTES, KC, and IL-12 [R&D Systems]; 
and mTNF [eBioscience]) according to the manufacturers’ protocols.
RNA isolation and quantitative RT-PCR. Samples from the small intes-
tine (0.5-cm segment, 2 cm distal to the pylorus) were collected at sacrifice 
and snap frozen for further analysis. Total RNA isolation was performed 
using TRIzol (Invitrogen). Exon–exon boundary-spanning primer sequences 
were obtained from PrimerBank, and sequences are listed in Table 1. Real-
time PCR was performed using 480 SYBR Green I master mix (Roche) and 
a LightCycler 480 system (Roche). Mouse GAPDH served as endogenous 
control. PCR was set up in triplicates, and threshold cycle (Ct) values of the 
target genes were normalized to the endogenous control. Differential expres-
sion was calculated according to the 2-CT method.
Blocking experiments. Monocyte-derived DCs were seeded at a concen-
tration of 1 × 106/ml in 96-well plates. Cells were preincubated with block-
ing antibodies (10 µg/ml rat anti-TLR4 [InvivoGen] and 20 µg/ml goat 
anti-CD14 [R&D Systems]) for 3 h at 37°C before stimulation.
Flow cytometry. Human monocyte-derived DCs were stimulated with 
LPS, PT gliadin, and PT zein overnight. For flow cytometry, cells were pre-
incubated with FcR blocking reagent (Miltenyi Biotec) for 15 min at 4°C 
before staining with monoclonal antibodies (final concentration 10 µg/ml; 
all from eBioscience) for 30 min at 4°C. Cells were then washed with staining 
Gliadin from the pure wheat strain Rektor was subfractionated as 
described previously (Wieser et al., 1998). In brief, -, -, 1.2-, and 
5-gliadins were obtained by HPLC purification on a Nucleosil C8 column 
(4.6 × 240 mm) at 50°C, using 0.1% trifluoroacetic acid as phase A and 
99.9% acetonitrile plus 0.1% trifluoroacetic acid as phase B and a gradient 
from 24% B to 56% B in 30 min. Detection was at 210 nm. Purity of the 
fractions was confirmed by SDS-PAGE, amino-terminal sequence analysis, 
and their characteristic amino acid composition.
Synthetic peptides. Peptide p31-43 of -gliadin (sequence LGQQQPFP-
PQQPY; Maiuri et al., 2003), a scrambled control peptide (sequence 
GLQPFQQPQPPQY), and the -gliadin 33mer (sequence LQLQPF-
PQPQLPYPQPQLPYPQPQPF), a potent stimulator of adaptive immunity 
(Shan et al., 2002), were synthesized by AnaSpec Inc. Purity of the peptides 
was >80% according to HPLC and mass spectrometry analysis. 43 20mer 
peptides with an overlap of 10 aa covering the 439-residue 5-gliadin were 
synthesized at 60–80% purity by Primm Biotechnology.
Cell culture and in vitro stimulation experiments. THP-1, U937, 
HEK-293 (all from American Type Culture Collection), and HEK-293 cells 
stably transfected with the TLR4–CD14–MD2 complex (InvivoGen) 
were cultured in complete RPMI or DMEM (Cellgro) supplemented with 
100 IU/ml penicillin/100 µg/ml streptomycin and 10% fetal calf serum at 
37°C in a 5% CO2 atmosphere. All cell lines were tested for mycoplasma 
contamination on a regular basis and proved to be mycoplasma free.
Peripheral monocytes were isolated from 40 ml blood obtained from 11 
patients with celiac disease (8 on a gluten-free and 3 on a gluten-containing 
diet) during their diagnostic workup (median 37 yr, range 18–59 yr) after 
prior informed consent, and healthy control monocytes were from buffy 
coats of leukopheresis concentrates of anonymous blood donors (approval 
#2006-P-000117/4, Institutional Review Board of the Beth Israel Deacon-
ess Medical Center). Peripheral blood mononuclear cells were isolated as 
described previously (Vissers et al., 1988), and CD14-positive monocytes 
were purified by MACS separation according to the manufacturer’s protocol 
(Miltenyi Biotec). For generation of DCs, monocytes were cultured in 
RPMI supplemented with 10% fetal calf serum, 200 U/ml rhIL-4, and 
300 U/ml rhGM-CSF (both from PeproTech) for 6–8 d.
Murine resident peritoneal macrophages were isolated by peritoneal 
lavage using a 3-ml syringe and 18G needles. 3 × 3 ml of sterile PBS was in-
jected into the peritoneal cavity and reaspirated after gentle massage of the 
abdomen (Fortier et al., 1982). For further purification, MACS separation 
for CD11b-positive cells was performed according to the manufacturer’s 
protocol. All animal experiments were approved by the review committee of 
the Beth Israel Deaconess Medical Center (protocol 031-2008).
To elicit IL-12 secretion, human DCs were stimulated with PT gliadin 
or ATI in the presence of 1,000 U/ml Interferon- as co-stimulatory protein. 
For stimulation, 106/ml cells were seeded in triplicates on polystyrene wells. 
Unless stated otherwise, supernatants were harvested 16 h after addition 
of the stimulants.
Exclusion of LPS contamination. To prove that stimulatory effects were 
caused by protein, PT gliadin, wheat ATI, LPS, or TNF was incubated with 
or without 20 µg/ml proteinase K (Promega) for 4 h at 56°C. After proteinase 
K inactivation by boiling for 5 min, the digests were used for cell stimulation.
Coimmunoprecipitation. A soluble flag-tagged TLR4/MD2 construct 
(gift of W. Falk, University of Regensburg, Regensburg, Germany; Brandl 
et al., 2005) was expressed in HEK-293 cells. The supernatant was harvested, 
and protein was concentrated using a 100-kD size exclusion cartridge (EMD 
Millipore). Purified wheat ATI was biotinylated using 10 mM N-Hydroxy-
sulfosuccinimide (NHS) esters of biotin solution according to the manufac-
turer’s protocol (Thermo Fisher Scientific). 1 µg of flag-tagged TLR4/MD2 
was then incubated with or without 10 µg ATI for 2 h at 4°C, followed by 
incubation with streptavidin-agarose for 1 h. Precipitates were boiled at 100°C, 
and eluates were run on a 4–20% gradient SDS gel followed by Western blot 
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PT gliadin, 200 µg/ml ATI, 50 µg/ml of synthetic -gliadin 33mer, or 
33mer and ATI. RNA was extracted, reverse transcribed, and analyzed 
by quantitative RT-PCR as described in the section RNA isolation and 
quantitative RT-PCR using the SYBR Green method and the primers 
listed in Table 1.
Statistical analysis. Differences were tested for statistical significance 
by one-way ANOVA multivariate analysis followed by Dunnett’s post-
test using Prism 4.01 software (GraphPad Software). P < 0.05 was con-
sidered significant. In all graphs, error bars depict standard errors of the 
mean. For injection and gavage experiments, at least three mice per 
group were used. Graphs illustrate representative data from one of at least 
three independent experiments.
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